Overview

Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of BMS-708163 administered as single and multiple doses in Chinese subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb